DE4392555T1 - Dipeptidylpeptidase I-Inhibitoren und deren Verwendung - Google Patents

Dipeptidylpeptidase I-Inhibitoren und deren Verwendung

Info

Publication number
DE4392555T1
DE4392555T1 DE4392555T DE4392555T DE4392555T1 DE 4392555 T1 DE4392555 T1 DE 4392555T1 DE 4392555 T DE4392555 T DE 4392555T DE 4392555 T DE4392555 T DE 4392555T DE 4392555 T1 DE4392555 T1 DE 4392555T1
Authority
DE
Germany
Prior art keywords
inhibitors
dipeptidyl peptidase
dipeptidyl
peptidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4392555T
Other languages
English (en)
Inventor
Dwain L Thiele
Peter E Lipsky
Michael J Mcguire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of DE4392555T1 publication Critical patent/DE4392555T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/12Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
    • C07C245/14Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12Sulfonium compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/14Dipeptidyl-peptidases and tripeptidyl-peptidases (3.4.14)
    • C12Y304/14001Dipeptidyl-peptidase I (3.4.14.1), i.e. cathepsin-C
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/33Chemical structure of the base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DE4392555T 1992-05-29 1993-05-28 Dipeptidylpeptidase I-Inhibitoren und deren Verwendung Withdrawn DE4392555T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/890,422 US5602102A (en) 1992-05-29 1992-05-29 Dipeptidyl peptidase-I inhibitors and uses thereof
PCT/US1993/005093 WO1993024634A1 (en) 1992-05-29 1993-05-28 Dipeptidyl peptidase-i, cloning it, and therapeutic agents containing inhibitors thereof

Publications (1)

Publication Number Publication Date
DE4392555T1 true DE4392555T1 (de) 1995-04-27

Family

ID=25396656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4392555T Withdrawn DE4392555T1 (de) 1992-05-29 1993-05-28 Dipeptidylpeptidase I-Inhibitoren und deren Verwendung

Country Status (4)

Country Link
US (1) US5602102A (de)
AU (1) AU4396993A (de)
DE (1) DE4392555T1 (de)
WO (1) WO1993024634A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7195926B1 (en) 1995-04-19 2007-03-27 Incyte Corporation Antibodies to a cathepsin C homolog
US5637462A (en) * 1995-04-19 1997-06-10 Incyte Pharmaceuticals, Inc. Cathepsin C homolog
US6458564B1 (en) 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
US20040047853A1 (en) * 2000-06-09 2004-03-11 Dahl Soren W Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
US20020037829A1 (en) * 2000-08-23 2002-03-28 Aronson Peter S. Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
US7736875B2 (en) * 2000-09-08 2010-06-15 Prozymex A/S Dipeptidyl peptidase I crystal structure and its uses
EP1470246A2 (de) * 2001-10-31 2004-10-27 Novartis AG Methoden zur behandlung von diabetes und ähnlicher zustände basierend auf polymorphismen des tcf1-gens
EP1465862A1 (de) 2002-01-17 2004-10-13 SmithKline Beecham Corporation Cycloalkyl-ketoamiden derivate und ihre verwendung als cathepsin-k-inhibitoren
EP1469875A1 (de) * 2002-01-29 2004-10-27 Wyeth Zusammensetzungen und methoden zur modulation der connexin hemikanäle
AU2003267967B2 (en) * 2002-06-18 2008-11-20 Zymogenetics, Inc. Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
WO2004038370A2 (en) * 2002-10-22 2004-05-06 Polytechnic University Enhancing the sensitivity of a microsphere sensor
WO2005019819A1 (en) 2003-08-20 2005-03-03 Biosite, Inc. Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
ES2308181T3 (es) 2003-05-30 2008-12-01 Prozymex A/S Inhibidores de proteasa.
US20070099958A1 (en) * 2003-06-18 2007-05-03 Prozymex A/S Protease inhibitors
EP1745292A2 (de) * 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnositka und therapeutika für mit dipeptidyl-peptidase 1 (dpp1) assoziierten krankheiten
WO2006127452A2 (en) * 2005-05-20 2006-11-30 Emory University Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
EP1942898B2 (de) 2005-09-14 2014-05-14 Takeda Pharmaceutical Company Limited Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8642111B2 (en) * 2009-05-19 2014-02-04 Polytechnic Institute Of New York University Functionalizing a sensing ribbon on a whispering gallery mode microresonator using light force to fabricate a whispering gallery mode sensor
CN114159446A (zh) * 2020-09-11 2022-03-11 中国科学院上海营养与健康研究所 组织蛋白酶c抑制剂在治疗肿瘤转移中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
US4752602A (en) * 1985-09-09 1988-06-21 Board Of Regents, The University Of Texas System Dipeptide alkyl esters and their uses
US5068223A (en) * 1985-09-09 1991-11-26 Board Of Regents, University Of Texas System Hydrophobic peptide esters and amides
US5403919A (en) * 1987-08-11 1995-04-04 Board Of Trustees Of The Leland Stanford Junior University Stanford University Method to control leukocyte extravasation
US5223486A (en) * 1988-11-01 1993-06-29 University Research Corporation Inhibition of cancer procoagulant
GB9119247D0 (en) * 1991-09-09 1991-10-23 Cookson Group Plc Novel polymers and their use in binder systems

Also Published As

Publication number Publication date
US5602102A (en) 1997-02-11
AU4396993A (en) 1993-12-30
WO1993024634A1 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
DE4392555T1 (de) Dipeptidylpeptidase I-Inhibitoren und deren Verwendung
CY2010015I2 (el) Φθοροαλκοξυ-υποκατεστημενα βeναμιδια και η χρησιμοποιηση τους σαν κυκλικοι-νουκλεοτιδικοι αναστολεις φωσφοδιεστερασης
EE9500045A (et) 6-lülilised lämmastikku sisaldavad heteroarüüloksasolidinoonid
DE59309352D1 (de) Multicistronische expressionseinheiten und deren verwendung
DE69412084D1 (de) Organosilizium materialien verwendbar in biomedizinischen vorrichtungen
NO2002010I2 (no) Ertapenem
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
DE69330634D1 (de) Tragbarer Rechner und Verfahren
FI943796A (fi) Kolmannen osapuolen laskutus
FI932695A0 (fi) Angiotensin I kymas-inhibitorer inklusive humant hjaertkymas
KR950704251A (ko) 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof)
DE69434482D1 (de) Verstärker
DE69319008D1 (de) Verstärker
DE69306405D1 (de) Bearbeitung von abfällen
DE69322737D1 (de) Verstärker
FI955165A0 (fi) 4-aryyli-4-hydroksi-tetrahydropyraanit ja 3-aryyli-3-hydroksi-tetrahydrofuraanit 5-lipoksygenaasi inhibiittoreina
DE69412008D1 (de) Operationsverstärker und Verfahren dazu
DE59310331D1 (de) Polyethersubstituierte Imidverbindungen sowie deren Verwendung
DE69416474D1 (de) Verstärker
AT399962B (de) Drilleiter
ITMI921571A1 (it) Azaciclo e azabiciclo alchiliden idrossilamine
FI1031U1 (fi) En troakar
DK83692D0 (da) Forbindelser
KR950007949U (ko) 씽크대용 작업판
KR960015255U (ko) 총·포알

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee